Cargando…
28552 Risk of COVID-19 and subsequent mortality among patients receiving immunosuppressive biologic therapy: A retrospective matched cohort study
| Autores principales: | , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Published by Mosby, Inc.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8349149/ http://dx.doi.org/10.1016/j.jaad.2021.06.030 |
| _version_ | 1783735506117328896 |
|---|---|
| author | Pahalyants, Vartan Murphy, William S. Klebanov, Nikolai Theodosakis, Nicholas Klevens, R. Monina Lilly, Evelyn Asgari, Maryam Semenov, Yevgeniy R. |
| author_facet | Pahalyants, Vartan Murphy, William S. Klebanov, Nikolai Theodosakis, Nicholas Klevens, R. Monina Lilly, Evelyn Asgari, Maryam Semenov, Yevgeniy R. |
| author_sort | Pahalyants, Vartan |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8349149 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Published by Mosby, Inc. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-83491492021-08-09 28552 Risk of COVID-19 and subsequent mortality among patients receiving immunosuppressive biologic therapy: A retrospective matched cohort study Pahalyants, Vartan Murphy, William S. Klebanov, Nikolai Theodosakis, Nicholas Klevens, R. Monina Lilly, Evelyn Asgari, Maryam Semenov, Yevgeniy R. J Am Acad Dermatol Article Published by Mosby, Inc. 2021-09 2021-08-07 /pmc/articles/PMC8349149/ http://dx.doi.org/10.1016/j.jaad.2021.06.030 Text en Copyright © 2021 Published by Mosby, Inc. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Article Pahalyants, Vartan Murphy, William S. Klebanov, Nikolai Theodosakis, Nicholas Klevens, R. Monina Lilly, Evelyn Asgari, Maryam Semenov, Yevgeniy R. 28552 Risk of COVID-19 and subsequent mortality among patients receiving immunosuppressive biologic therapy: A retrospective matched cohort study |
| title | 28552 Risk of COVID-19 and subsequent mortality among patients receiving immunosuppressive biologic therapy: A retrospective matched cohort study |
| title_full | 28552 Risk of COVID-19 and subsequent mortality among patients receiving immunosuppressive biologic therapy: A retrospective matched cohort study |
| title_fullStr | 28552 Risk of COVID-19 and subsequent mortality among patients receiving immunosuppressive biologic therapy: A retrospective matched cohort study |
| title_full_unstemmed | 28552 Risk of COVID-19 and subsequent mortality among patients receiving immunosuppressive biologic therapy: A retrospective matched cohort study |
| title_short | 28552 Risk of COVID-19 and subsequent mortality among patients receiving immunosuppressive biologic therapy: A retrospective matched cohort study |
| title_sort | 28552 risk of covid-19 and subsequent mortality among patients receiving immunosuppressive biologic therapy: a retrospective matched cohort study |
| topic | Article |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8349149/ http://dx.doi.org/10.1016/j.jaad.2021.06.030 |
| work_keys_str_mv | AT pahalyantsvartan 28552riskofcovid19andsubsequentmortalityamongpatientsreceivingimmunosuppressivebiologictherapyaretrospectivematchedcohortstudy AT murphywilliams 28552riskofcovid19andsubsequentmortalityamongpatientsreceivingimmunosuppressivebiologictherapyaretrospectivematchedcohortstudy AT klebanovnikolai 28552riskofcovid19andsubsequentmortalityamongpatientsreceivingimmunosuppressivebiologictherapyaretrospectivematchedcohortstudy AT theodosakisnicholas 28552riskofcovid19andsubsequentmortalityamongpatientsreceivingimmunosuppressivebiologictherapyaretrospectivematchedcohortstudy AT klevensrmonina 28552riskofcovid19andsubsequentmortalityamongpatientsreceivingimmunosuppressivebiologictherapyaretrospectivematchedcohortstudy AT lillyevelyn 28552riskofcovid19andsubsequentmortalityamongpatientsreceivingimmunosuppressivebiologictherapyaretrospectivematchedcohortstudy AT asgarimaryam 28552riskofcovid19andsubsequentmortalityamongpatientsreceivingimmunosuppressivebiologictherapyaretrospectivematchedcohortstudy AT semenovyevgeniyr 28552riskofcovid19andsubsequentmortalityamongpatientsreceivingimmunosuppressivebiologictherapyaretrospectivematchedcohortstudy |